| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
,
IVAN GERLING,
ÅKE LERNMARK,
PETER MACKAY and
ALEXANDER RABINOVITCH
Hagedorn Research Laboratory, DK-2820 Gentofte Denmark
Address all correspondence and requests for reprints to: Åke Lernmark, M.D., Director of Research, Hagedorn Research Laboratory, Niels Steensensvej 6, DK-2820 Gentofte, Denmark.
We used the mouse passive transfer model to test whether islet cell antibodies affect β-cell function. The immunoglobulin (Ig) fraction of plasma from 5 islet cell surface antibody-positive, newly diagnosed insulin-dependent diabetic children or of a pool of plasma from 12 normal subjects was injected daily (7–16 mg IgG/day) for 14 days into normal immunosuppressed BALB/c mice. Insulin secretory responses in the Ig-injected mice were then examined by perfusing the rodent pancreata in vitro. Insulin release induced by 20 mmol/liter Dglucose during 30 min of stimulation decreased from 900 ng insulin (median; range, 814–1138) from pancreata of mice injected with control Ig to 511 ng (range, 130–786) from pancreata of mice injected with diabetic Ig (P < 0.003). Both the initial peak and the sustained second phase of glucose-stimulated insulin release were depressed in 4 of the 5 pancreata from mice injected with diabetic Ig. These results indicate that circulating antibodies in diabetic children may alter β-cell function and possibly contribute to the pathogenesis of insulin-dependent diabetes.
* This work was supported in part by NIH Grant AM-26190.
Supported by a fellowship from the University of Copenhagen Medical Faculty.
Supported by NIH Research Career Development Award 5K04-AM-00552.
Received April 20, 1983.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |